NEW YORK – Kernal Biologics on Tuesday said the Advanced Research Projects Agency for Health (ARPA-H) awarded the company up to $48 million to support development of its in vivo mRNA-encoded CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback